Should You Hold Simulations Plus (SLP)?

By Yahoo! Finance | Aug 16, 2024 at 02:53 AM EST

Conestoga Capital Advisors released its Q2 2024 investor letter discussing market moderation. They highlighted Simulations Plus, Inc. (NASDAQ:SLP), focusing on AI technology for drug development. SLP saw a decline in stock value but showed solid revenue growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.